Copyright Reports & Markets. All rights reserved.

Global Point of Care (POC) Diagnostic Devices Market Professional Survey Report 2019

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Point of Care (POC) Diagnostic Devices Industry
  • 1.7 COVID-19 Impact: Point of Care (POC) Diagnostic Devices Market Trends

    • 2 Global Point of Care (POC) Diagnostic Devices Quarterly Market Size Analysis

    • 2.1 Point of Care (POC) Diagnostic Devices Business Impact Assessment - COVID-19
      • 2.1.1 Global Point of Care (POC) Diagnostic Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Point of Care (POC) Diagnostic Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Point of Care (POC) Diagnostic Devices Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Point of Care (POC) Diagnostic Devices Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Point of Care (POC) Diagnostic Devices Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Point of Care (POC) Diagnostic Devices Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Point of Care (POC) Diagnostic Devices Market
    • 3.5 Key Manufacturers Point of Care (POC) Diagnostic Devices Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Point of Care (POC) Diagnostic Devices Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Miniaturization and Microfluidics Technology
      • 1.4.2 Molecular Diagnostics
      • 1.4.3 Non-Invasive Technology
      • 1.4.4 Others
    • 4.2 By Type, Global Point of Care (POC) Diagnostic Devices Market Size, 2019-2021
      • 4.2.1 By Type, Global Point of Care (POC) Diagnostic Devices Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Point of Care (POC) Diagnostic Devices Price, 2020-2021

    5 Impact of Covid-19 on Point of Care (POC) Diagnostic Devices Segments, By Application

    • 5.1 Overview
      • 5.5.1 Patient Self-Testing
      • 5.5.2 Clinics
      • 5.5.3 Hospitals
      • 5.5.4 Laboratories
      • 5.5.5 Others
    • 5.2 By Application, Global Point of Care (POC) Diagnostic Devices Market Size, 2019-2021
      • 5.2.1 By Application, Global Point of Care (POC) Diagnostic Devices Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Point of Care (POC) Diagnostic Devices Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Roche Diagnostics
      • 7.1.1 Roche Diagnostics Business Overview
      • 7.1.2 Roche Diagnostics Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.1.3 Roche Diagnostics Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.1.4 Roche Diagnostics Response to COVID-19 and Related Developments
    • 7.2 Abaxis
      • 7.2.1 Abaxis Business Overview
      • 7.2.2 Abaxis Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.2.3 Abaxis Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.2.4 Abaxis Response to COVID-19 and Related Developments
    • 7.3 Abbott POC
      • 7.3.1 Abbott POC Business Overview
      • 7.3.2 Abbott POC Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.3.3 Abbott POC Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.3.4 Abbott POC Response to COVID-19 and Related Developments
    • 7.4 Abbott
      • 7.4.1 Abbott Business Overview
      • 7.4.2 Abbott Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.4.3 Abbott Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.4.4 Abbott Response to COVID-19 and Related Developments
    • 7.5 Beckman Coulter
      • 7.5.1 Beckman Coulter Business Overview
      • 7.5.2 Beckman Coulter Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.5.3 Beckman Coulter Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.5.4 Beckman Coulter Response to COVID-19 and Related Developments
    • 7.6 Beckton and Dickinson
      • 7.6.1 Beckton and Dickinson Business Overview
      • 7.6.2 Beckton and Dickinson Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.6.3 Beckton and Dickinson Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.6.4 Beckton and Dickinson Response to COVID-19 and Related Developments
    • 7.7 Bayer Diabetes Care
      • 7.7.1 Bayer Diabetes Care Business Overview
      • 7.7.2 Bayer Diabetes Care Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.7.3 Bayer Diabetes Care Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.7.4 Bayer Diabetes Care Response to COVID-19 and Related Developments
    • 7.8 Hemocue AB
      • 7.8.1 Hemocue AB Business Overview
      • 7.8.2 Hemocue AB Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.8.3 Hemocue AB Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.8.4 Hemocue AB Response to COVID-19 and Related Developments
    • 7.9 International Technidyne Corporation
      • 7.9.1 International Technidyne Corporation Business Overview
      • 7.9.2 International Technidyne Corporation Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.9.3 International Technidyne Corporation Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.9.4 International Technidyne Corporation Response to COVID-19 and Related Developments
    • 7.10 LifeScan Inc
      • 7.10.1 LifeScan Inc Business Overview
      • 7.10.2 LifeScan Inc Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.10.3 LifeScan Inc Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.10.4 LifeScan Inc Response to COVID-19 and Related Developments
    • 7.11 Nipro Diagnostics
      • 7.11.1 Nipro Diagnostics Business Overview
      • 7.11.2 Nipro Diagnostics Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.11.3 Nipro Diagnostics Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.11.4 Nipro Diagnostics Response to COVID-19 and Related Developments
    • 7.12 Orasure Technologies
      • 7.12.1 Orasure Technologies Business Overview
      • 7.12.2 Orasure Technologies Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.12.3 Orasure Technologies Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.12.4 Orasure Technologies Response to COVID-19 and Related Developments
    • 7.13 PointCare Technologies
      • 7.13.1 PointCare Technologies Business Overview
      • 7.13.2 PointCare Technologies Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.13.3 PointCare Technologies Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.13.4 PointCare Technologies Response to COVID-19 and Related Developments
    • 7.14 Siemens HealthCare Diagnostics
      • 7.14.1 Siemens HealthCare Diagnostics Business Overview
      • 7.14.2 Siemens HealthCare Diagnostics Point of Care (POC) Diagnostic Devices Quarterly Production and Revenue, 2020
      • 7.14.3 Siemens HealthCare Diagnostics Point of Care (POC) Diagnostic Devices Product Introduction
      • 7.14.4 Siemens HealthCare Diagnostics Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Point of Care (POC) Diagnostic Devices Supply Chain Analysis
      • 8.1.1 Point of Care (POC) Diagnostic Devices Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Point of Care (POC) Diagnostic Devices Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Point of Care (POC) Diagnostic Devices Distribution Channels
      • 8.2.2 Covid-19 Impact on Point of Care (POC) Diagnostic Devices Distribution Channels
      • 8.2.3 Point of Care (POC) Diagnostic Devices Distributors
    • 8.3 Point of Care (POC) Diagnostic Devices Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Point of Care (POC) Diagnostic Devices, including the following market information:
      Global Point of Care (POC) Diagnostic Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Point of Care (POC) Diagnostic Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Point of Care (POC) Diagnostic Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Point of Care (POC) Diagnostic Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Roche Diagnostics, Abaxis, Abbott POC, Abbott, Beckman Coulter, Beckton and Dickinson, Bayer Diabetes Care, Hemocue AB, International Technidyne Corporation, LifeScan Inc, Nipro Diagnostics, Orasure Technologies, PointCare Technologies, Siemens HealthCare Diagnostics, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Miniaturization and Microfluidics Technology
      Molecular Diagnostics
      Non-Invasive Technology
      Others

      Based on the Application:
      Patient Self-Testing
      Clinics
      Hospitals
      Laboratories
      Others

      Buy now